ARDT Ardent Health, Inc.

$11.73 -2.41%

Data as of Nov 2, 2026 close

Healthcare · Services-General Medical & Surgical Hospitals, Nec

Ardent Health, Inc. (ARDT) is a healthcare company in the Services-General Medical & Surgical Hospitals, Nec industry, with a market capitalization of $1.7 billion. Shares last traded at $11.73, 21.4% below their 52-week high. Over the past year the stock is down 19.5%. ARDT trades at a price-to-earnings ratio of 21.15, above the Services-General Medical & Surgical Hospitals, Nec median of 8.23. Net profit margin is 1.2%, below the peer median of 4.8%. Revenue grew 6.0% year over year.

Market Cap

$1.7B

Shares Out

141.0M

EPS (TTM)

$0.55

P/E (TTM)*

21.15

P/S Ratio

0.26

P/B Ratio

1.23

Dividend / Share

—

Dividend Yield

—

52-Week High

$14.93

52-Week Low

$7.72

Volume (venue)

15,563

Avg Vol (3m, venue)

24,698.175

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

-3.81%

+13.44%

+9.07%

+17.65%

YTD

+32.99%

-19.49%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.99

SMA (50)

$11.18

SMA (200)

$10.00

Price vs SMA50

+4.91%

Price vs SMA200

+17.34%

ATR (14)

$0.40

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$6.4B

Net Income

$78M

Gross Margin

—

Operating Margin

—

Net Margin

1.2%

Return on Equity

5.8%

Return on Assets

1.5%

Current Ratio

2.10

Debt / Equity

0.79

Revenue Growth (YoY)

+6.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.12	2026-08-10
Q1 2026	$0.28	2026-05-06
Q4 2025 (derived)	$0.32	2026-03-16
FY 2025	$0.96	2026-03-16
Q3 2025	-$0.17	2025-11-14
Q2 2025	$0.52	2025-08-06

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-General Medical & Surgical Hospitals, Nec peers

ARDT vs 6 industry peers (Services-General Medical & Surgical Hospitals, Nec), by market cap. Data as of Nov 2, 2026 close

P/E vs peers

21.15 / 8.23 med

+157% premium

P/S vs peers

0.26 / 0.74 med

-65% discount

Net margin vs peers

1.2% / 4.8% med

below median

1–6 of 6


HCA	HCA Healthcare	$97.7B	14.42	1.24	8.6%	-1.15%
THC	Tenet Healthcare Corp	$21.4B	5.60	0.96	17.2%	-1.64%
UHS	Universal Health Services	$10.6B	6.98	0.59	8.4%	+2.67%
SGRY	Surgery Partners, Inc.	$3.0B	—	0.90	-2.6%	-0.26%
ARDT	Ardent Health, Inc.	$1.7B	21.15	0.26	1.2%	-2.41%
CYH	Community Health Systems Inc	$296M	8.23	0.03	0.3%	-12.13%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.